Met Life Investment Management, LLC Alkermes Plc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 96,695 shares of ALKS stock, worth $3.36 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

96,695

Previous 93,203 3.75%

Holding current value

$3.36 Million

Previous $2.61 Million 6.6%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$25.7 - $31.46 $89,744 - $109,858	3,492 Added 3.75%	96,695 $2.78 Million
Q3 2024 Nov 13, 2024	SELL	$23.01 - $28.55 $91,993 - $114,142	-3,998 Reduced 4.11%	93,203 $2.61 Million
Q2 2024 Aug 13, 2024	BUY	$23.21 - $27.24 $266,915 - $313,260	11,500 Added 13.42%	97,201 $2.34 Million
Q1 2024 May 14, 2024	BUY	$26.4 - $32.56 $2.26 Million - $2.79 Million	85,701 New	85,701 $2.32 Million
Q3 2023 May 09, 2024	BUY	$27.17 - $31.97 $58,469 - $68,799	2,152 Added 2.52%	87,431 $2.45 Million
Q2 2023 Apr 29, 2024	BUY	$28.34 - $33.63 $2.48 Million - $2.94 Million	87,431 New	87,431 $2.74 Million
Q2 2023 Aug 10, 2023	BUY	$28.34 - $33.63 $60,987 - $72,371	2,152 Added 2.52%	87,431 $2.74 Million
Q1 2023 May 09, 2024	BUY	$25.31 - $29.02 $2.16 Million - $2.47 Million	85,279 New	85,279 $2.4 Billion
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $2.16 Million - $2.47 Million	85,279 New	85,279 $2.4 Million
Q4 2022 Jun 14, 2023	BUY	$21.94 - $26.24 $31,505 - $37,680	1,436 Added 1.68%	86,715 $2.27 Billion
Q3 2022 May 10, 2024	BUY	$22.0 - $31.87 $48,004 - $69,540	2,182 Added 2.58%	86,715 $1.94 Million
Q3 2022 Jun 14, 2023	BUY	$22.0 - $31.87 $31,592 - $45,765	1,436 Added 1.68%	86,715 $1.94 Billion
Q2 2022 May 10, 2024	SELL	$26.4 - $30.54 $47,968 - $55,491	-1,817 Reduced 2.1%	84,533 $2.52 Million
Q2 2022 Jun 20, 2023	SELL	$26.4 - $30.54 $19,694 - $22,782	-746 Reduced 0.87%	84,533 $2.52 Billion
Q1 2022 May 10, 2024	BUY	$23.07 - $27.99 $1.99 Million - $2.42 Million	86,350 New	86,350 $2.27 Million
Q1 2022 Jun 20, 2023	BUY	$23.07 - $27.99 $24,707 - $29,977	1,071 Added 1.26%	86,350 $2.27 Billion
Q4 2021 Jun 21, 2023	SELL	$21.47 - $32.08 $597,037 - $892,080	-27,808 Reduced 32.61%	57,471 $1.34 Billion
Q3 2021 Jun 21, 2023	SELL	$23.37 - $32.13 $649,872 - $893,471	-27,808 Reduced 32.61%	57,471 $1.77 Billion
Q2 2021 May 17, 2024	SELL	$18.78 - $25.15 $530,159 - $709,984	-28,230 Reduced 32.94%	57,471 $1.41 Million
Q2 2021 Jun 21, 2023	SELL	$18.78 - $25.15 $522,234 - $699,371	-27,808 Reduced 32.61%	57,471 $1.41 Billion
Q1 2019 Jul 13, 2023	SELL	$28.4 - $36.49 $2.42 Million - $3.1 Million	-85,068 Reduced 99.75%	211 $7.7 Million
Q4 2018 Jul 13, 2023	SELL	$27.94 - $44.61 $2.38 Million - $3.79 Million	-85,069 Reduced 99.75%	210 $6.2 Million
Q3 2018 Jul 13, 2023	SELL	$38.6 - $46.12 $3.28 Million - $3.92 Million	-85,067 Reduced 99.75%	212 $9 Million

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

166M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.71B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Alkermes Plc. Transaction History